GCIA
TECX

Gabelli & Co Investment Advisers’s Tectonic Therapeutic TECX Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-29,417
Closed -$480K – 277
2023
Q4 		$480K Buy
+29,417
New +$505K 0.09% 123

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gabelli & Co Investment Advisers's TECX Position: Q1 2024 in Review

Gabelli & Co Investment Advisers sold out of Tectonic Therapeutic (TECX) in Q1 2024, closing a stake of 29,417 shares — an estimated $480K sold.

Gabelli & Co Investment Advisers first reported a position in TECX in Q4 2023 and held it in 1 quarter. The position peaked at $480K in Q4 2023. 46 funds tracked by Wall St. Rank hold TECX as of Q1 2024.

  • Gabelli & Co Investment Advisers reported no remaining Tectonic Therapeutic position as of Q1 2024 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 29,417 Tectonic Therapeutic shares in Q1 2024, an estimated $480K.
  • Gabelli & Co Investment Advisers first reported a position in Tectonic Therapeutic in Q4 2023 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Tectonic Therapeutic position peaked at $480K in Q4 2023.
  • 46 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2024.

Based on Gabelli & Co Investment Advisers's 13F filing for Q1 2024, filed 14 May 2024.